What Fotmer Life Sciences does

Fotmer Life Sciences is a privately held Uruguayan medical cannabis company founded in 2016 and headquartered in Montevideo. Per the firmographic record, the company operates as a cultivator and extractor within Uruguay's regulated medical cannabis framework (Law 19.172, enacted 2013), one of the earliest national legal regimes for medical cannabis globally. The company employs between 101 and 250 people, indicating a mid-sized production operation rather than a boutique or hobby-scale cultivator. Its website is registered at fotmer.com, though live corporate content was not retrievable from the source capture.

The company's stated role as both cultivator and extractor implies an integrated vertical scope spanning raw plant production through to extracted formats (oils, distillates, or isolates) typically used in pharmaceutical-grade medical cannabis products. No product catalog, formulation details, active ingredient concentrations, strain portfolio, GMP certification status, or extraction technology specifics are documented in the available data. No patient-facing pharmacy, telehealth, or distribution channel is referenced, leaving the downstream commercial posture unclear.

Business model mechanics — including pricing, customer mix (domestic pharmacy channel vs. export vs. white-label contract manufacturing), revenue per gram, or contract structure — are not disclosed in the input data. The only captured source was a CAPTCHA verification placeholder on fotmer.com and provided no first-party content. As a result, the description of revenue mechanics, customer segments, and go-to-market motion is necessarily limited to what can be inferred from the cultivator/extractor classification and Uruguayan regulatory context.

Name

Fotmer Life Sciences

Website

https://fotmer.com

Company type

Private

Founded year

2016

Headcount range

101–250 employees

Short description

Fotmer Life Sciences is a privately held Uruguayan medical cannabis cultivator and extractor, founded in 2016 in Montevideo, employing 101–250 staff, operating under Uruguay's regulated cannabis framework.

Ownership category

akta.pro rank

Product category

Medical Cannabis Cultivation & Extraction

NAICS

Medicinal and Botanical Manufacturing (325411)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Medicinal Plant Farming (Botanical/Pharmaceutical Crops) (AFAGAGAE)

Keywords

• Medical cannabis cultivation
• Cannabis extraction services
• Pharmaceutical cannabis inputs
• Cannabis biomass production
• Medicinal cannabis processing

Headquarters

HQ city

Montevideo

HQ country

Uruguay

HQ region

Latin America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain

Core offering

Fotmer Life Sciences cultivates and extracts medical-grade cannabis, producing raw plant material and cannabis extracts for downstream medical and pharmaceutical channels. The company is positioned as a producer/processor within Uruguay's regulated medical cannabis supply chain.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical cannabis cultivation Controlled cultivation of medical-grade cannabis biomass for licensed downstream pharmaceutical and medicinal buyers in Uruguay.
• Cannabis extraction services Post-harvest extraction of cultivated cannabis into processed extracts for licensed buyers in the medical/pharmaceutical supply chain.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights2 records

Direct peers

• ICC Labs (now part of Aurora Cannabis): ICC Labs was a Uruguay-based medical cannabis cultivator with operations co-located with Fotmer in Montevideo. Direct geographic and vertical overlap (cultivation in Uruguay targeting medical export markets) makes it the closest historical comparable.
• Clever Leaves: Clever Leaves is a Colombia-based licensed cultivator, extractor, and producer of pharmaceutical-grade cannabis APIs serving international B2B buyers. Closely comparable vertically integrated cultivation-plus-extraction API business model serving medical markets.
• PharmaCielo: PharmaCielo is a Colombia-headquartered cultivator and processor of medicinal-grade cannabis extracts for global distribution. Comparable upstream cultivation-and-extraction model targeting international pharmaceutical and wellness buyers.
• Khiron Life Sciences: Khiron is a LatAm-focused medical cannabis company with cultivation, extraction, and clinical product lines, operating across Colombia and other jurisdictions. Comparable medical-cannabis cultivation plus value-added product strategy targeting EU and LatAm markets.

Broad incumbents

• Canopy Growth: Canopy Growth is one of the largest global cannabis companies with diversified cultivation, extraction, and branded medical/recreational product portfolios. Comparable cultivation-and-extraction core capability, but at much larger scale and broader geographic footprint.
• Tilray Brands: Tilray is a global cannabis cultivator and product company with significant medical cannabis operations including cultivation, extraction, and EU-GMP-certified production. Overlaps with Fotmer on the upstream API/supply side of the medical cannabis value chain.
• Aurora Cannabis: Aurora Cannabis is a major Canadian-licensed cannabis producer with medical cannabis cultivation and extraction globally, and notably acquired ICC Labs in Uruguay. Directly comparable medical cannabis cultivation footprint, including LatAm presence.
• Organigram Holdings: Organigram is a Canadian licensed producer of medical and recreational cannabis with established cultivation and extraction operations. Comparable medical-grade cultivation-and-extraction business serving B2B and B2C medical channels.
• Cronos Group: Cronos Group is a global cannabis company with cultivation, production, and distribution across multiple geographies. Overlaps with Fotmer in the upstream medical cannabis cultivation and ingredient space, though at substantially larger scale.

Regional players

• Cannabis S.A. (Uruguay): Cannabis S.A. is one of Uruguay's licensed cannabis producers operating under the country's IRCCA regulatory framework alongside Fotmer. Directly comparable domestic Uruguayan cultivation-and-extraction peer competing in the same local ecosystem.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/fotmerlife
• Facebookfacebook.com/FotmerLifeSciences
• LinkedInlinkedin.com/company/fotmerlifesciences

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fotmer Life Sciences